Griffin Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Griffin Asset Management, Inc.

$879 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$71.58 - $87.29 $29,848 - $36,399	-417 Reduced 2.46%	16,550 $1.21 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $35,535 - $40,298	-485 Reduced 2.78%	16,967 $1.37 Million
Q3 2023 Oct 19, 2023	SELL	$73.94 - $80.67 $41,997 - $45,820	-568 Reduced 3.15%	17,452 $1.31 Million
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $9,881 - $11,271	130 Added 0.73%	18,020 $1.39 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $26,053 - $29,682	-337 Reduced 1.85%	17,890 $1.48 Million
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $18,509 - $26,572	297 Added 1.66%	18,227 $0
Q3 2022 Oct 19, 2022	SELL	$59.54 - $68.01 $9,288 - $10,609	-156 Reduced 0.86%	17,930 $1.11 Million
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $39,711 - $44,726	688 Added 3.95%	18,086 $1.12 Million
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $5,096 - $6,387	-88 Reduced 0.5%	17,398 $1.03 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $34,710 - $39,397	535 Added 3.16%	17,486 $1.27 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $8,325 - $8,982	-123 Reduced 0.72%	16,951 $1.18 Million
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $5,077 - $5,548	-80 Reduced 0.47%	17,074 $1.18 Million
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $14,400 - $16,430	240 Added 1.42%	17,154 $1.11 Million
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $36,086 - $41,118	637 Added 3.91%	16,914 $985,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $81,351 - $102,284	1,310 Added 8.75%	16,277 $1.03 Million
Q2 2020 Aug 18, 2020	SELL	$72.34 - $84.0 $38,412 - $44,604	-531 Reduced 3.43%	14,967 $1.15 Million
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $25,991 - $33,291	-415 Reduced 2.61%	15,498 $1.16 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $47,755 - $52,529	775 Added 5.12%	15,913 $1.03 Million
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $4,688 - $5,175	-75 Reduced 0.49%	15,138 $959,000
Q2 2019 Aug 19, 2019	SELL	$61.87 - $69.38 $406,795 - $456,173	-6,575 Reduced 30.18%	15,213 $1.03 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $495,862 - $555,496	-7,930 Reduced 26.68%	21,788 $1.42 Million
Q4 2018 Mar 01, 2019	SELL	$60.54 - $79.0 $13,076 - $17,064	-216 Reduced 0.72%	29,718 $1.86 Million
Q3 2018 Nov 19, 2018	BUY	$71.28 - $78.92 $102,785 - $113,802	1,442 Added 5.06%	29,934 $2.31 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $103,483 - $120,709	-1,595 Reduced 5.3%	28,492 $2.02 Million
Q1 2018 May 16, 2018	BUY	$72.84 - $88.8 $213,202 - $259,917	2,927 Added 10.78%	30,087 $2.27 Million
Q4 2017 Feb 20, 2018	BUY	$71.15 - $83.52 $46,247 - $54,288	650 Added 2.45%	27,160 $1.95 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $738,694 - $875,554	10,244 Added 62.98%	26,510 $2.15 Million
Q2 2017 Aug 29, 2017	BUY	N/A	16,266	16,266 $1.15 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account